Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IDCRP-154: Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

NCT07287137 is registered in ClinicalTrials.gov with Henry M. Jackson Foundation for the Advancement of Military Medicine as lead sponsor.

NCT NCT07287137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07287137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IDCRP-154: Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase
Phase 4
Overall status
Active, not recruiting
Start date
November 12, 2025
Completion date
September 30, 2027
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid - 19, covid -19, covid 19, influenza, respiratory virus, respiratory virus infection, respiratory virus infections, respiratory viruses